Follow directions. Likewise, if the listing asks applicants not to call or email, respect that. Following up after an employer has specifically asked applicants not to may make you appear pushy and ...

Capricor Therapeutics is expected to release data from the phase 3 HOPE-3 trial in Q3'25, thus presenting a potential path ...

The FDA published a database of letters sent to drugmakers during the review process of medications that provide information on the agency's initial feedback or requirements for more data. These ...

Capricor Therapeutics (CAPR) shares fell Friday after the company announced it received a complete response letter from the FDA for its Biologics License Application for Deramiocel.

The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as ...

The FDA has published more than 200 complete response letters, sent as replies for applications submitted from 2020 to 2024.

As the controversial powerline fight continues, the developers have begun sending out letters to residents about surveys starting, however the letter raises mor ...